Last $14.51 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Francis James Thomas Fildes Ph.D., DSc (Hon), FRSC

Director, Member of Scientific Advisory Board, Chairman of Compensation Committee and Member of Audit Committee, Flamel Technologies SA
AgeTotal Calculated CompensationThis person is connected to 24 board members in 2 different organizations across 4 different industries.

See Board Relationships
70--

Background*

Dr. Francis James Thomas Fildes, also known as Frank, PhD, DSc (Hon), FRSC served as an Advisor of Merlin Biosciences Limited. Dr. Fildes is a Consultant to the pharmaceutical and biotech industries. From 1999 to 2002, Dr. Fildes served as Senior Vice President and Head of Global Development of AstraZeneca PLC until December 2002 and was responsible for the development, registration, and technical support of AstraZeneca products worldwide. A physical chemist by training, ...

Read Full Background

Corporate Headquarters*

Parc Club du Moulin à Vent
Vénissieux, Rhône-Alpes 69693

France

Phone: 33 472 78 34 34
Fax: 33 472 78 34 35

Board Members Memberships*

Former Director
2003-N/A
Former Non Executive Director and Member of Nomination Committee
2004-Present
Non-Executive Director
2008-Present
Director, Member of Scientific Advisory Board, Chairman of Compensation Committee and Member of Audit Committee

Education*

Unknown/Other Education
University of Liverpool

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FLML:US $14.51 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Ronald W. Barrett Ph.D.Co-Founder, Chief Executive Officer and Director
Xenoport, Inc.
$500.0K
Judith Greciet Ph.D., PharmacyChief Executive Officer, Director and Member of Corporate Development Committee
BioAlliance Pharma
€276.9K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FLAMEL TECHNOLOGIES-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.